Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EBIT Growth(%) 11.358.1124.0847.24-21.19

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 11.35 based on Mar2026 Consolidated results.
Year EBIT Growth
Mar202611.35
Mar20258.11
Mar202424.08
Mar202347.24
Mar2022-21.19

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2026 11.35
39.95
Mar2025 8.11
-66.32
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹169,293.1 Cr 2% 12.1% 49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,870.0 Cr 0.8% 8.3% 17.1% Stock Analytics
DIVIS LABORATORIES ₹194,316.0 Cr 7.1% 9% 4.2% Stock Analytics
CIPLA ₹115,477.0 Cr -0.7% 4.1% -3.6% Stock Analytics
MANKIND PHARMA ₹105,107.0 Cr 0.8% 8% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹102,156.0 Cr -1.7% -4.2% -3.1% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2%

12.1%

49.6%

SENSEX

0.6%

1.2%

-7.8%


You may also like the below Video Courses